Personalized dosing may boost chemo power in stubborn testicular cancers
NCT ID NCT00864318
First seen Apr 22, 2026 · Last updated May 12, 2026 · Updated 5 times
Summary
This study tested a two-step high-dose chemotherapy plan for 101 people with germ cell tumors that returned or didn't respond to initial treatment. The approach used paclitaxel and ifosfamide first, then carboplatin and etoposide, with carboplatin doses tailored to each patient to reduce side effects like hearing loss. The goal was to see if this personalized dosing could improve complete response rates while keeping toxicity manageable.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GERM CELL TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU
Clermont-Ferrand, 63003, France
-
CHU
Strasbourg, 67091, France
-
Centre Antoine Lacassagne
Nice, 06050, France
-
Centre Léon Bérard
Lyon, 69373, France
-
Centre Paul Papin
Angers, 49933, France
-
Hopital St André
Bordeaux, 33075, France
-
Hopital TENON
Paris, 75970, France
-
Institut Bergonié
Bordeaux, 33076, France
-
Institut Claudius Regaud
Toulouse, 31052, France
-
Institut Gustave Roussy
Villejuif, 94805, France
-
Institut Paoli Calmette
Marseille, 13273, France
-
Institut Val d'aurelle
Montpellier, 34298, France
Conditions
Explore the condition pages connected to this study.